The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.

Autor:	Cavallari, LH, Beitelshees, AL, Blake, KV, Dressler, LG, Duarte, JD, Elsey, A, Eichmeyer, JN, Empey, PE, Franciosi, JP, Hicks, JK, Holmes, AM, Jeng, LJB, Lee, CR, Lima, JJ, Limdi, NA, Modlin, J, Obeng, AO, Petry, N, Pratt, VM., Skaar, TC
Předmět:	MEDICAL genomics PHARMACOGENOMICS GENOTYPES PLATELET aggregation inhibitors PERCUTANEOUS coronary intervention
Zdroj:	CTS: Clinical & Translational Science; May2017, Vol. 10 Issue 3, p143-146, 4p
Abstrakt:	The article focuses on the establishment of the Implementing GeNomics In praTticE (IGNITE) network or Pharmacogenetics Working Group which aim to support the investigation and development of genomic medicine practice models. Topics discussed include the use of pharmacogenetic testing in assisting prescribing decisions, CYP2C19 genotyping for prediction of clopidogrel response, and guide antiplatelet therapy for percutaneous coronary intervention (PCI).
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.